Abstract:Small molecule kinase inhibitors (SMKIs) are of heightened interest in the field of drug research and development. There are 79 (as of July 2023) small molecule kinase inhibitors that have been approved by the FDA and hundreds of kinase inhibitor candidates in clinical trials that have shed light on the treatment of some major diseases. As an important strategy in drug design, computer-aided drug design (CADD) plays an indispensable role in the discovery of SMKIs. CADD methods such as docking, molecular dynamic, quantum mechanics/molecular mechanics, pharmacophore, virtual screening, and quantitative structure–activity relationship have been applied to the design and optimization of small molecule kinase inhibitors. In this review, we provide an overview of recent advances in CADD and SMKIs and the application of CADD in the discovery of SMKIs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to use computer - aided drug design (CADD) methods to develop new, highly effective and selective kinase inhibitors (SMKIs). Specifically, the article focuses on the following aspects: 1. **The importance of kinases in diseases**: Kinases play a crucial role in processes such as cell metabolism, growth, differentiation and division, and are closely related to the signal pathways of many human diseases (such as cancer, cardiovascular diseases, diabetes, inflammation and degenerative diseases). Therefore, kinases have become important targets for drug research and development. 2. **Limitations of existing kinase inhibitors**: Currently, 79 small - molecule kinase inhibitors have been approved by the FDA, and many candidates are in the clinical trial stage. However, due to the high conservation of the kinase ATP - binding site, existing kinase inhibitors often have off - target effects (i.e., low selectivity), leading to adverse side effects. Therefore, finding new, highly effective and selective kinase inhibitors remains an important challenge. 3. **Application of computer - aided drug design (CADD)**: CADD can promote the discovery of kinase inhibitors by analyzing the subtle differences and structural features of different kinase ATP - binding sites. The article particularly emphasizes the application of structure - based drug design (SBDD) and ligand - based drug design (LBDD) in the development of kinase inhibitors, including methods such as molecular docking, molecular dynamics, quantum mechanics/molecular mechanics, pharmacophore models, virtual screening and quantitative structure - activity relationships. 4. **Improving the efficiency of drug research and development**: The traditional drug research and development process is time - consuming, costly and has a low success rate. CADD significantly reduces the research and development cost, shortens the research and development cycle and improves the research and development efficiency by rationally designing new chemical entity molecules. In summary, this paper aims to summarize and discuss the latest progress of CADD in the development of new kinase inhibitors, especially how to overcome the selectivity problem of existing kinase inhibitors through CADD methods, so as to provide new ideas and tools for future drug research and development.

An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis

A Guide to In Silico Drug Design

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives

Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process

FDA-approved small molecule kinase inhibitors for cancer treatment (2001-2015): Medical indication, structural optimization, and binding mode Part I

An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19

Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis

Research on the application of computer in drug design

Computer-aided drug design for AMP-activated protein kinase activators.

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs

CADD Methods for Developing Novel Compounds Synthesized to Inhibit Tyrosine Kinase Receptors

Progress of Computer-Aided Drug Design (CADD) of Proteasome Inhibitors.

Advances in computer-aided drug design for type 2 diabetes

State-of-the-art technology in modern computer-aided drug design

Rational Design of Covalent Kinase Inhibitors by an Integrated Computational Workflow (Kin-Cov)

Integrated Molecular Modeling and Machine Learning for Drug Design

Current Developments of Computer-Aided Drug Design

Structure-Based Approach For In-Silico Drug Designing

Trends in kinase drug discovery: targets, indications and inhibitor design